Division of Oncology, Departments of Medicine and Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Department of Chemistry, Stanford University, Stanford, CA 94305, USA.
Cell Metab. 2019 Sep 3;30(3):556-572.e5. doi: 10.1016/j.cmet.2019.07.012. Epub 2019 Aug 22.
Lipid metabolism is frequently perturbed in cancers, but the underlying mechanism is unclear. We present comprehensive evidence that oncogene MYC, in collaboration with transcription factor sterol-regulated element-binding protein (SREBP1), regulates lipogenesis to promote tumorigenesis. We used human and mouse tumor-derived cell lines, tumor xenografts, and four conditional transgenic mouse models of MYC-induced tumors to show that MYC regulates lipogenesis genes, enzymes, and metabolites. We found that MYC induces SREBP1, and they collaborate to activate fatty acid (FA) synthesis and drive FA chain elongation from glucose and glutamine. Further, by employing desorption electrospray ionization mass spectrometry imaging (DESI-MSI), we observed in vivo lipidomic changes upon MYC induction across different cancers, for example, a global increase in glycerophosphoglycerols. After inhibition of FA synthesis, tumorigenesis was blocked, and tumors regressed in both xenograft and primary transgenic mouse models, revealing the vulnerability of MYC-induced tumors to the inhibition of lipogenesis.
脂质代谢在癌症中经常受到干扰,但潜在的机制尚不清楚。我们提供了全面的证据表明,癌基因 MYC 与转录因子固醇调节元件结合蛋白(SREBP1)合作,调节脂肪生成以促进肿瘤发生。我们使用人源和鼠源肿瘤衍生细胞系、肿瘤异种移植物以及四种 MYC 诱导肿瘤的条件性转基因小鼠模型,表明 MYC 调节脂肪生成基因、酶和代谢物。我们发现 MYC 诱导 SREBP1,它们合作激活脂肪酸(FA)合成,并从葡萄糖和谷氨酰胺驱动 FA 链延长。此外,通过采用解吸电喷雾电离质谱成像(DESI-MSI),我们观察到在不同癌症中 MYC 诱导后的体内脂质组学变化,例如甘油磷酸甘油酯的全面增加。抑制 FA 合成后,肿瘤发生被阻断,异种移植和原发性转基因小鼠模型中的肿瘤消退,揭示了 MYC 诱导的肿瘤对脂肪生成抑制的脆弱性。